✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals
Market Cap
₹284 Cr.
P/E
38.16
  • Sanjivani Paranteral
  • Zenotech Laboratorie
  • Lyka Labs

FAQs on Sanjivani Paranteral Ltd. Shareprice

Sanjivani Paranteral has given better returns compared to its competitors.
Sanjivani Paranteral has grown at ~80.94% over the last 7yrs while peers have grown at a median rate of 22.14%

Yes, Sanjivani Paranteral is expensive.
Latest PE of Sanjivani Paranteral is 37.57, while 3 year average PE is 25.16.
Also latest EV/EBITDA of Sanjivani Paranteral is 28.71 while 3yr average is 20.79.

Growth Table

  • Sanjivani Paranteral Ltd.
  • Zenotech Laboratorie
  • Lyka Labs

Balance Sheet

  • Sanjivani Paranteral Ltd.
  • Zenotech Laboratorie
  • Lyka Labs

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Sanjivani Paranteral Ltd.
  • Zenotech Laboratorie
  • Lyka Labs

Cash Flow

  • Sanjivani Paranteral Ltd.
  • Zenotech Laboratorie
  • Lyka Labs

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Sanjivani Paranteral Ltd.
  • Zenotech Laboratorie
  • Lyka Labs

Quarterly Results

  • Sanjivani Paranteral Ltd.
  • Zenotech Laboratorie
  • Lyka Labs

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*

FAQs on Sanjivani Paranteral Ltd. Financials

Balance sheet of Sanjivani Paranteral is strong.
But short term working capital might become an issue for this company.

Yes, The net debt of Sanjivani Paranteral is increasing.
Latest net debt of Sanjivani Paranteral is ₹8.61 Crs as of Sep-25.
This is greater than Mar-25 when it was ₹3.33 Crs.

The profit is oscillating.
The profit of Sanjivani Paranteral is ₹7.45 Crs for TTM, ₹8.1 Crs for Mar 2025 and ₹6.17 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Sanjivani Paranteral latest dividend payout ratio is 7.34% and 3yr average dividend payout ratio is 7.34%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Capital Work in Progress, Accounts Receivable

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech